| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.098 | 0.03 |